It can be seen from the figure that ABCA5 is involved in the immune response to a variety of cancers, including BLCA (bladder cancer), COAD (colon adenocarcinoma), BRCA (breast cancer), KICH (kidney chromophobe), KIRC (kidney renal clear cell carcinoma), THCA (thyroid carcinoma), THYM (thymoma), and UCEC (uterine corpus endometrial carcinoma), with strong relevance to immune cells, including KICH, TGCT (tenosynovial giant cell tumor), and THYM (Figure S3). Here, ABCA5 is linked to cancer.